logo
Finding ALK-Positive Lung Cancer
Acknowledgment of Reviewers
Maintaining Aim at a Moving Target
p16Ink4a Suppression of Lung Adenocarcinoma by Bmi-1 in the Presence of p38 Activation
Foxp3+ Regulatory T Cells and Natural Killer Cells Distinctly Infiltrate Primary Tumors and Draining Lymph Nodes in Pulmonary Adenocarcinoma
Lovastatin Sensitizes Lung Cancer Cells to Ionizing Radiation
Suitability of Thoracic Cytology for New Therapeutic Paradigms in Non-small Cell Lung Carcinoma
Correlation of IHC and FISH for ALK Gene Rearrangement in Non-small Cell Lung Carcinoma
Screening of Anaplastic Lymphoma Kinase Rearrangement by Immunohistochemistry in Non-small Cell Lung Cancer
p63 and p73 Isoform Expression in Non-small Cell Lung Cancer and Corresponding Morphological Normal Lung Tissue
miR-1254 and miR-574-5p
Accuracy of Fine Needle Aspiration Cytology in the Pathological Typing of Non-small Cell Lung Cancer
The Impact of Superior Mediastinal Lymph Node Metastases on Prognosis in Non-small Cell Lung Cancer Located in the Right Middle Lobe
Variation in Comorbidity and Clinical Management in Patients Newly Diagnosed with Lung Cancer in Four Scottish Centers
Causes and Consequences of Deviation from Multidisciplinary Care in Thoracic Oncology
Spontaneous Smoking Cessation Before Lung Cancer Diagnosis
Screening-Detected Lung Cancers
Tumor Regression and Positional Changes in Non-small Cell Lung Cancer During Radical Radiotherapy
Treatment of the Elderly When Cure is the Goal
Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in the Local Treatment of Primary and Secondary Intrathoracic Malignancies
Phase II Trial of Induction Gemcitabine and Carboplatin Followed by Conformal Thoracic Radiation to 74 Gy with Weekly Paclitaxel and Carboplatin in Unresectable Stage III Non-small Cell Lung Cancer
Antagonism between Gefitinib and Cisplatin in Non-small Cell Lung Cancer Cells
Impact on Disease-Free Survival of Adjuvant Erlotinib or Gefitinib in Patients with Resected Lung Adenocarcinomas that Harbor EGFR Mutations
Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer
Aromatase Inhibitor Exemestane has Antiproliferative Effects on Human Mesothelioma Cells
Thoracoscopic Assessment of Pleural Tumor Burden in Patients with Malignant Pleural Effusion
A Practical Guide of the Southwest Oncology Group to Measure Malignant Pleural Mesothelioma Tumors by RECIST and Modified RECIST Criteria
Accuracy of Diagnostic Biopsy for the Histological Subtype of Malignant Pleural Mesothelioma
Expression of Excision Repair Cross-Complementation Group 1, Breast Cancer Susceptibility 1, and β III-Tubulin in Thymic Epithelial Tumors
Management of Thymic Tumors
A Case Series of Dose-Limiting Peripheral Edema Observed in Patients Treated with Pemetrexed
Frequency and Type of Epidermal Growth Factor Receptor Mutations in African Americans with Non-small Cell Lung Cancer
Persistent Part-Solid Nodule in the Lung Represents Pulmonary Adenocarcinoma
T4 or MI?
The Outcome of Medical Intensive Care for Lung Cancer Patients
First Case of A859T Epidermal Growth Factor Receptor Mutation Responding to Erlotinib
Successful Treatment with Pemetrexed in a Patient with Mucinous Bronchioloalveolar Carcinoma
A Rare Case of Endobronchial Amelanotic Melanoma
Summary of Presentations from the 46th Annual Meeting of the American Society of Clinical Oncology (2010)
On Plain Language and Going Astray
Reply to “On Plain Language and Going Astray”
Bevacizumab Chemotherapy for Pulmonary Epithelioid Hemangioendothelioma with Severe Dyspnea
Excision Repair Cross-Complementing-1 for Small Cell Lung Cancer
Excision Repair Cross-Complementing-1 for Small Cell Lung Cancer
High-dose Erlotinib for Refractory Brain Metastases in a Patient with Relapsed Non-small Cell Lung Cancer